ID: h-debate-fff879b3edd9
Hypothesis

Chaperone Hijacking Interference Therapy

Pathological proteins may hijack endogenous chaperone networks during intercellular transfer, creating transmission bottlenecks.
🧬 HSP70🎯 Composite 0%💱 $0.51▲1.1%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.44 (8%) 0.000 composite

🧪 Overview

Pathological proteins may hijack endogenous chaperone networks during intercellular transfer, creating transmission bottlenecks. Deploying competitive chaperone decoys that specifically bind transmission-competent protein conformations could redirect them away from transfer pathways into degradation routes.

Debate provenance: derived from debate `sess_SDA-2026-04-08-gap-pubmed-20260406-062207-5a703c17` on question: While the abstract establishes that intercellular transmission occurs for various proteins (tau, α-synuclein, TDP-43), the mechanisms governing transmission selectivity and efficiency remain poorly understood. This gap impedes development of transmission-blocking therapeutics.

Gap type: unexplained. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Chaperone, HSP70, Hijacking, Interference. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for HSP70

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    HSP70["HSP70"] -->|associated with| Intercellular_Protein_Tra["Intercellular Protein Transmission"]
    HSP90_inhibitors["HSP90 inhibitors"] -->|associated with| neurodegeneration["neurodegeneration"]
    PERK["PERK"] -->|regulates| pathological_protein_tran["pathological protein transfer"]
    sess_SDA_2026_04_08_gap_p["sess_SDA-2026-04-08-gap-pubmed-20260406-062207-5a703c17"] -->|causal extracted| processed["processed"]
    style HSP70 fill:#ce93d8,stroke:#333,color:#000
    style Intercellular_Protein_Tra fill:#4fc3f7,stroke:#333,color:#000
    style HSP90_inhibitors fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style PERK fill:#4fc3f7,stroke:#333,color:#000
    style pathological_protein_tran fill:#4fc3f7,stroke:#333,color:#000
    style sess_SDA_2026_04_08_gap_p fill:#4fc3f7,stroke:#333,color:#000
    style processed fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — HSP70

No curated PDB or AlphaFold mapping for HSP70 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for HSP70 →

No DepMap CRISPR Chronos data found for HSP70.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
15,004
$0.0900
Total Cost
$0.0900
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.